Abstract |
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in solid tumors. We report the novel benzimidazole analogue AC1-004, obtained from a chemical library using an HRE-dependent cell-based assay in colorectal carcinoma HCT-116 cells. The accumulation of hypoxia-induced HIF-1alpha was inhibited by compound AC1-004 in various cancer cells, including HCT-116, MDA-MB435, SK-HEP1, and Caki-1. Further, AC1-004 down-regulated VEGF and EPO, target genes of HIF-1, and inhibited in vitro tube formation of HUVEC, suggesting its potential inhibitory activity on angiogenesis. Importantly, AC1-004 was found to regulate the stability of HIF-1alpha through the Hsp90-Akt pathway, leading to the degradation of HIF-1alpha. An in vivo antitumor study demonstrated that AC1-004 reduced tumor size significantly (i.e., by 58.6%), without severe side effects. These results suggest the benzimidazole analogue AC1-004 is a novel HIF inhibitor that targets HIF-1alpha via the Hsp90-Akt pathway, and that it can be used as a new lead in developing anticancer drugs.
|
Authors | Mi-Sun Won, Namhui Im, Soohyun Park, Shanthaveerappa K Boovanahalli, Yinglan Jin, Xuejun Jin, Kyung-Sook Chung, Moorim Kang, Kiho Lee, Song-Kyu Park, Hwan Mook Kim, Byoung Mog Kwon, Jung Joon Lee, Kyeong Lee |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 385
Issue 1
Pg. 16-21
(Jul 17 2009)
ISSN: 1090-2104 [Electronic] United States |
PMID | 19433063
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- AC1 004
- Antineoplastic Agents
- Benzimidazoles
- HSP90 Heat-Shock Proteins
- Hypoxia-Inducible Factor 1, alpha Subunit
- Proto-Oncogene Proteins c-akt
- Adamantane
|
Topics |
- Adamantane
(analogs & derivatives, chemistry, pharmacology)
- Antineoplastic Agents
(chemistry, pharmacology)
- Benzimidazoles
(chemistry, pharmacology)
- Cell Line, Tumor
- Drug Design
- HSP90 Heat-Shock Proteins
(metabolism)
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
(antagonists & inhibitors)
- Proto-Oncogene Proteins c-akt
(metabolism)
|